EE565 Cost-Utility Analysis of Dupilumab in Adults and Adolescents With Uncontrolled Persistent Severe Asthma in Portugal
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.805
https://www.valueinhealthjournal.com/article/S1098-3015(22)03009-1/fulltext
Title :
EE565 Cost-Utility Analysis of Dupilumab in Adults and Adolescents With Uncontrolled Persistent Severe Asthma in Portugal
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03009-1&doi=10.1016/j.jval.2022.09.805
First page :
Section Title :
Open access? :
No
Section Order :
10342